| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 05/15/2002 | EP0865278B1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 05/15/2002 | CN1349529A Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 05/15/2002 | CN1348799A Externally applied medicine for treating crab-louse disease |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036584A1 Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles |
| 05/10/2002 | WO2002036138A1 A head lice formulation |
| 05/10/2002 | WO2002002088A3 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001034157A9 Protease inhibitors |
| 05/10/2002 | WO2001003681A3 Use of flavones, coumarins and related compounds to treat infections |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427489A1 A head lice formulation |
| 05/10/2002 | CA2427267A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/09/2002 | US20020055537 Treating a crop infected with a phytopathogenic animal pest; treatment of vertebrates and humans infested by helminths or ectoparasites. |
| 05/09/2002 | US20020055183 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202749A2 Enzyme catalyzed anti-infective therapeutic agents |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/08/2002 | CN1348373A Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis |
| 05/07/2002 | US6384052 Anticoccidial compounds |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | CA2223700C In ovo vaccination against coccidiosis |
| 05/07/2002 | CA2214884C Poly(hydroxy acid)/polymer conjugates for skin applications |
| 05/02/2002 | WO2002035242A1 Method for identifying novel molecules binding with lox receptor |
| 05/02/2002 | WO2002035236A1 Method for identifying novel molecules binding with the scavenger receptors and signalled via a toll receptor |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002034239A1 Use of hydrophilic particles associated with antigens for preparing vaccine compositions |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001035949A3 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001007651A3 Transposon mediated differential hybridisation |
| 05/02/2002 | US20020052513 Oxamide IMPDH inhibitors |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052328 Useful as antibacterial and antiprotozoal agents in mammals, including man, as well as in fish and birds. |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201251A1 Stratified and cryogenically stored vaccines, process for their preparation |
| 05/02/2002 | EP1201250A1 Immunogenic compositions comprising liver stage malarial antigens |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200112A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | CA2062496C Avermectin compounds with a 6,5-spiroketal ring system |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033050A2 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | WO2002032905A1 Medicinal compositions, dose and method for treating malaria |
| 04/25/2002 | WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | WO2002032426A1 Further improvements in and relating to the control of coccidia |
| 04/25/2002 | WO2001072831A3 Immunoregulator |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049218 2-, 6, and 9-substituted purine derivatives, particularly 2(1-R hydroxymethylpropylamino)-6-benzylamino-9-isopropyl purine, used as drug and herbicide; inhibiting effect with respect to cyclin-dependent kinase proteins |
| 04/25/2002 | US20020048587 Containing an antigen or at least one in vivo generator of a compound comprising an amino acid sequence. |
| 04/25/2002 | US20020048583 Combining ex vivo an antigen and an antigen-presenting cell binding agent specific for the antigen, and administering the composition to a patient suffering from a disease associated with the antigen |
| 04/25/2002 | US20020048576 Enzyme that cleaves a linkage that effects release of a cell-surface protein or carbohydrate and a physiologically acceptable carrier for said enzyme; form suitable for oral administration. |
| 04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | CA2426103A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425727A1 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/24/2002 | EP1198243A2 Use of cpg as an adjuvant for malaria vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | CN1346362A Avermectin derivatives |
| 04/24/2002 | CN1346267A Combination preparation for treating malaria |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/24/2002 | CN1083445C Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 04/23/2002 | US6376658 Used as therapeutics for malaria |
| 04/23/2002 | US6376511 8-aminoquinolines |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6376196 Contacting sample with isolated immunodominant neospora antigen, thereby forming antigen/antibody complex and detecting presence of antibodies specifically immunoreactive with bovine neospora antigen |
| 04/18/2002 | WO2002030909A1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030458A1 Yersinia adhesion protein as vaccine adjuvant |
| 04/18/2002 | WO2002030434A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | WO2002030410A2 Suppression of cyclin kinase activity for prevention and treatment of infections |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001072777A3 Human transcription factors |